With confocal laser endomicroscopy and the use of fluorescent labeled anti-TNF antibodies, they assessed the expression of membrane-bound TNF (mTNF) on intestinal cells of 25 CD patients about to start treatment with adalimumab. This evidence concerns the gene TNF and Cowden disease.